用于体内基因编辑的类似病毒的微粒在小鼠DFNA2模型中改善听力损失
Byunghwa Noh1, Ramu Gopalappa2, Haiyue Lin3
1Department of Otorhinolaryngology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Republic of Korea; Won-Sang Lee Institute for Hearing Loss, Seoul 03722, Republic of Korea.
Molecular therapy : the journal of the American Society of Gene Therapy
|September 3, 2025
概括
通过纠正Kcnq4突变, 研制的类似病毒的颗粒有效地将基因编辑器传递到内耳, 通过纠正Kcnq4突变, 成功治疗小鼠的渐进性听力损失.
科学领域:
- 耳鼻喉科
- 遗传学
- 分子生物学
背景情况:
- 基因编辑对治疗人类疾病具有前景, 但它的效率和安全性, 特别是对于内耳应用, 需要进一步研究.
- 将非病毒基因编辑器输送到内耳具有重大挑战.
- 渐进性听力损失可能是由KCNQ4等基因突变引起的.
研究的目的:
- 研究工程病毒样颗粒 (eVLPs) 传递基因编辑器到内耳的有效性和安全性.
- 使用eVLPs传递SpCas9和单导向RNA来纠正导致小鼠听力损失的Kcnq4突变等位基因.
主要方法:
- 设计的病毒样颗粒 (eVLPs) 已被开发用于内耳输送.
- 在Kcnq4突变小鼠 (Kcnq4W277S/+) 的内耳中通过eVLP输送了SpCas9和单导引RNA.
- 治疗的目标是表达Kcnq4的外皮毛细胞 (OHC).
主要成果:
- 在eVLP使用7周后,听力损失显著减轻.
- 外部毛细胞存活率和OHC抑制神经元完整性得到显著改善.
- 治疗eVLP基因编辑器导致OHC膜潜力高极化,表明细胞更健康.
结论:
- 工程病毒样粒子 (eVLP) 是内耳基因编辑器的可行传递系统.
- 通过eVLP调节的基因编辑可以有效治疗由KCNQ4突变引起的听力损失.
- 这种方法为开发听力损失新疗法提供了有前途的策略.
相关概念视频
01:16In-vitro Mutagenesis
14.2K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.2K
02:15Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K